Matches in Wikidata for { <http://www.wikidata.org/entity/Q90595382> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q90595382 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90595382 description "scientific article published on 09 October 2019" @default.
- Q90595382 description "wetenschappelijk artikel" @default.
- Q90595382 description "наукова стаття, опублікована 9 жовтня 2019" @default.
- Q90595382 name "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" @default.
- Q90595382 name "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" @default.
- Q90595382 type Item @default.
- Q90595382 label "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" @default.
- Q90595382 label "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" @default.
- Q90595382 prefLabel "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" @default.
- Q90595382 prefLabel "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" @default.
- Q90595382 P1433 Q90595382-0F98328C-0DAD-4E7D-A4A0-D2A5332AF5A5 @default.
- Q90595382 P1476 Q90595382-FB2F0BF8-A777-4261-AA8A-43AA547A3D9C @default.
- Q90595382 P2093 Q90595382-0B36CB47-9477-4130-B538-EB24DA249432 @default.
- Q90595382 P304 Q90595382-E5FD3282-96B1-4D98-AFA3-32A135EC1C7B @default.
- Q90595382 P31 Q90595382-770F7551-ADBA-4EB2-B72A-7B7BAFF0D9B0 @default.
- Q90595382 P356 Q90595382-241DC33F-457C-4E82-A29C-5E399C40996F @default.
- Q90595382 P50 Q90595382-A274932F-1A76-48E2-8E57-62EDDAFDC87E @default.
- Q90595382 P577 Q90595382-804EF0F7-B536-43AA-94C9-1D82FAC73368 @default.
- Q90595382 P698 Q90595382-F255DAFA-905F-49ED-821E-7A6543589CD2 @default.
- Q90595382 P921 Q90595382-1F956CA7-E0BD-4443-A3FF-B45FDCBC47AD @default.
- Q90595382 P921 Q90595382-C61C27B2-ED8D-4781-8F4F-2D4EC3CA2CF9 @default.
- Q90595382 P356 1078155219877923 @default.
- Q90595382 P698 31594517 @default.
- Q90595382 P1433 Q6295681 @default.
- Q90595382 P1476 "Durable response after interruption of nivolumab in patients with metastatic renal cell carcinoma: Is renal toxicity a marker to predict the benefit of nivolumab?" @default.
- Q90595382 P2093 "Gokmen Aktas" @default.
- Q90595382 P304 "1078155219877923" @default.
- Q90595382 P31 Q13442814 @default.
- Q90595382 P356 "10.1177/1078155219877923" @default.
- Q90595382 P50 Q90595378 @default.
- Q90595382 P577 "2019-10-09T00:00:00Z" @default.
- Q90595382 P698 "31594517" @default.
- Q90595382 P921 Q1164529 @default.
- Q90595382 P921 Q19000948 @default.